Immunome News

Express News | CORRECTION: Immunome Did Not Report Q1 Earnings On May 13, 2024

BenzingaMay 13 08:25 ET

Express News | Immunome Q1 EPS $(0.52) Beats $(0.81) Estimate

BenzingaMay 13 08:09 ET

TD Cowen Sticks to Their Buy Rating for Immunome (IMNM)

TipRanksMay 13 07:56 ET

Express News | Immunome Appoints Kinney Horn as Chief Business Officer

ReutersMay 2 08:00 ET

Immunome Announces Executive Shift, Welcomes New Accounting Officer

TipRanksApr 30 16:12 ET

Immunome Initiated at Overweight by JP Morgan

Immunome Initiated at Overweight by JP Morgan

Dow JonesApr 30 08:55 ET

JPMorgan Starts Immunome With Overweight Rating, $24 Price Target

JPMorgan Starts Immunome With Overweight Rating, $24 Price Target.

MT NewswiresApr 30 07:29 ET

Analysts Offer Insights on Healthcare Companies: Immunome (IMNM), Dyne Therapeutics (DYN) and Dexcom (DXCM)

TipRanksApr 30 05:01 ET

Express News | Immunome Inc : JP Morgan Initiates Coverage With Overweight Rating; Price Target $24

ReutersApr 30 00:22 ET

Immunome Appoints Sandra Swain and Revises Audit Committee

TipRanksApr 25 16:12 ET

Express News | Immunome Appoints Sandra M. Swain to Board of Directors

ReutersApr 25 08:26 ET

Express News | Immunome Inc : Guggenheim Initiates Coverage With Buy Rating and $35 Target Price

Moomoo 24/7Apr 15 07:42 ET

Immunome Initiated at Buy by Guggenheim

Immunome Initiated at Buy by Guggenheim

Dow JonesApr 15 06:43 ET

Express News | Guggenheim Initiates Coverage On Immunome With Buy Rating, Announces Price Target of $35

Moomoo 24/7Apr 15 06:34 ET

Analysts Offer Insights on Healthcare Companies: Genmab (GMAB), AbbVie (ABBV) and Immunome (IMNM)

TipRanksApr 8 03:50 ET

Retail Investors Who Have a Significant Stake Must Be Disappointed Along With Institutions After Immunome, Inc.'s (NASDAQ:IMNM) Market Cap Dropped by US$264m

Key Insights Immunome's significant retail investors ownership suggests that the key decisions are influenced by shareholders from the larger public A total of 21 investors have a majority stake in

Simply Wall StApr 5 10:41 ET

Immunome to Present Preclinical Data for IM-3050, Its Lead Radioligand Therapy Candidate, at 2024 American Association for Cancer Research (AACR) Annual Meeting

BOTHELL, Wash.--(BUSINESS WIRE)--Immunome, Inc. (Nasdaq: IMNM), a biotechnology company focused on developing first-in-class and best-in-class targeted cancer therapies, today announced that it will p

BusinesswireApr 5 08:00 ET

Express News | Immunome Files For Shelf Of Up To 2.2M Shares Of Common Stock By Selling Stockholder

Moomoo 24/7Apr 3 16:51 ET

Express News | Immunome Inc Filed Prospectus Relates To Proposed Resale From Time To Time By Selling Stockholder Of 2.3M Shares, Or Shares, Of Common Stock

Moomoo 24/7Apr 3 16:49 ET

Immunome Files to Sell 2.18M Common Shares for Holders

Seeking AlphaApr 3 16:44 ET